AΩA Speaker

Start Date

21-4-2023 3:15 PM

End Date

21-4-2023 4:00 PM

Location

Ballroom West

Abstract

Carolyn D. Runowicz, MD, is a tenured professor of obstetrics and gynecology at the FIU Herbert Wertheim College of Medicine. A nationally and internationally recognized leader in women's health and gynecologic cancer, her research has focused on clinical trials in gynecologic cancer and cancer prevention. She has authored more than 200 scientific articles and five books.

Dr. Runowicz has served in leadership roles in major cancer organizations, including the Board of Directors of the American Society of Clinical Oncology, The Society of Gynecologic Oncologists (president), the American Cancer Society (president), the American Gynecological and Obstetrical Foundation Board (vice president), and the National Cancer Advisory Board (appointed by President George W. Bush).

She is a reviewer for several medical journals and sits on several scientific advisory boards and expert review panels, including the National Cancer Institute and the Ovarian Cancer Research Foundation.

This document is currently not available here.

Share

COinS
 
Apr 21st, 3:15 PM Apr 21st, 4:00 PM

AΩA Speaker

Ballroom West

Carolyn D. Runowicz, MD, is a tenured professor of obstetrics and gynecology at the FIU Herbert Wertheim College of Medicine. A nationally and internationally recognized leader in women's health and gynecologic cancer, her research has focused on clinical trials in gynecologic cancer and cancer prevention. She has authored more than 200 scientific articles and five books.

Dr. Runowicz has served in leadership roles in major cancer organizations, including the Board of Directors of the American Society of Clinical Oncology, The Society of Gynecologic Oncologists (president), the American Cancer Society (president), the American Gynecological and Obstetrical Foundation Board (vice president), and the National Cancer Advisory Board (appointed by President George W. Bush).

She is a reviewer for several medical journals and sits on several scientific advisory boards and expert review panels, including the National Cancer Institute and the Ovarian Cancer Research Foundation.